Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension

Platelets

Volumn 13, Issue 7, 2002, Pages 395-399

  Haznedaroǧlu, Ibrahim C ^a   Atalar, Enver ^a   Öztürk, M Akif ^a   Özer, Necla ^a   Övüņ, Kenan ^a   Aksöyek, Serdar ^a   Kes, Sirri ^a   Kirazli, Serafettin ^a   Özmen, Ferhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPOIETIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; MALE; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPOIESIS; AGED; BLOOD; BLOOD VESSEL; CHEMISTRY; HEART VENTRICLE; LUNG; LUNG CIRCULATION; METABOLISM; MIDDLE AGED; VASCULARIZATION;

MUS MUSCULUS;

ADULT; AGED; BLOOD VESSELS; FEMALE; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY CIRCULATION; THROMBOPOIETIN;

EID: 0036849571     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Zucker-Franklin D, Philipp CS. Platelet production in the pulmonary capillary bed: New ultrastructural evidence for an old concept. Am J Pathol 2000; 157: 69-74.
2. Lunetta P, Penttila A. Pulmonary platelet production: Physical fragmentation and platelet territories. Eur J Haematol 1997; 59: 63-4.
3. Martin JF, Slater DN, Trowbridge EA. Platelet production in the lungs. Agents Actions Suppl 1987; 21: 37-57.
4. Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood 1965; 26: 720-31.
5. Aliberti G, Proietta M, Pulignano I, Tritapepe L, Di Giovanni C, Schiappoli A, et al. The lungs and platelet production. Clin Lab Haematol 2002; 24: 161-4.
6. Slater DN, Trowbridge EA, Martin JF. The megakaryocyte in thrombocytopenia: A microscopic study which supports the theory that platelets are produced in the pulmonary circulation. Thromb Res 1983; 31: 163-76.
7. Kaushansky K. Thrombopoietin: The primary regulator of megakaryocyte and platelet production. Thromb Haemost 1995; 74: 521-5.
8. Fawcett J, Huat OS, Williams N. The roles of factors from lung in murine megakaryocytopoiesis. Exp Hematol 1989; 17: 25-9.
9. Sharma GK, Talbot IC. Pulmonary megakaryocytes: 'Missing link' between cardiovascular and respiratory disease? J Clin Pathol 1986; 39: 969-76.
10. Chess Q. Megakaryocytes in bronchial brushings. Acta Cytol 1988; 32: 130-1.
11. Chen KT. Megakaryocytes in a fine needle aspirate of the lung. Acta Cytol 1987; 31: 81-2.
12. Bendix-Hansen K, Aabo K. Distribution of intrapulmonary megakaryocytes. Acta Pathol Microbiol Scand 1981; 89: 169-71.
13. Airo R. Pulmonary megakaryocyte increase after phlebotomy in rabbits. Haematologica 1978; 63: 548-54.
14. Hansen KB, Aabo K. Megakaryocytes in pulmonary blood vessels. 2. Relations to malignant haematological diseases especially leukaemia. Acta Pathol Microbiol Scand 1978; 86: 293-5.
15. Aabo K, Hansen KB. Megakaryocytes in pulmonary blood vessels. I. Incidence at autopsy, clinicopathological relations especially to disseminated intravascular coagulation. Acta Pathol Microbiol Scand 1978; 86: 285-91.
16. Crosby WH. Normal platelet numbers. Pulmonary-platelet interactions. Ser Haematol 1975; 8: 89-97.
17. Pedersen NT. The pulmonary vessels as a filter for circulating megakaryocytes in rats. Scand J Haematol 1974; 13: 225-31.
18. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-30.
19. Nagata Y, Shozaki Y, Nagahisa H, Nagasawa T, Abe T, Todokoro K. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemost 1997; 77: 808-14.
20. Altun B, Arici M, Haznedaroglu IC, Usalan C, Erdem Y, Yasavul U, et al. Serum thrombopoietin levels in haemodialysis patients: Involvement of arteriovenous fistula. Nephrol Dial Transplant 1999; 14: 2173-7.
21. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001; 120: 801-8.
22. Garcia-Manero G, Schuster SJ, Patrick H, Martinez J. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol 1999; 60: 130-5.
23. Zhou W, Toombs CF, Zou T, Guo J, Robinson MO. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 1997; 89: 1551-9.
24. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, et al. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation. Blood 1996; 88: 402-9.
25. Wolber EM, Dame C, Fahnenstich H, Hofmann D, Bartmann P, Jelkmann W, et al. Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood 1999; 94: 97-105.
26. Racz A, Brass N, Heckel D, Pahl S, Remberger K, Meese E. Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur J Cancer 1999; 35: 641-6.
27. Kristensen SD, Bath PM, Gladwin AM, Martin JF. The relationship between increased platelet count and megakaryocyte size in bronchial carcinoma. Br J Haematol 1992; 81: 247-51.
28. Ogata K, Kuriya I. Megakaryocyte-platelet hematopoietic factor produced by human lung cancer cell line (MC-1). Rinsho Ketsueki 1992; 33: 629-32.
29. Nurden P, Poujol C, Nurden AT. The evolution of megakaryocytes to platelets. Baillieres Clin Haematol 1997; 10: 1-27.
30. Dzieciol J. Are the lungs a thrombocytopoietic organ? Pol Tyg Lek 1994; 49: 408-10.
31. Sulkowski S, Sulkowska M, Musiatowicz B. The effects of cyclophosphamide on pulmonary thrombopoiesis in rats. Histol Histopathol 1998; 13: 1027-36.
32. Davis RE, Stenberg PE, Levin J, Beckstead JH. Localization of megakaryocytes in normal mice and following administration of platelet antiserum, 5-fluorouracil, or radiostrontium: Evidence for the site of platelet production. Exp Hematol 1997; 25: 638-48.
33. Warheit DB, Salley SO, Barnhart MI. Thrombin-stimulated effects on megakaryocytopoiesis and pulmonary-platelet interactions. Gen Physiol Biophys 1989; 8: 611-31.
34. Scott GB. Circulating megakaryocytes. Histopathology 1982; 6: 467-75.
35. Sulkowski S, Terlikowski S, Sulkowska M. Occlusion of pulmonary vessels by megakaryocytes after treatment with tumour necrosis factor-alpha (TNF-alpha). J Comp Pathol 1999; 120: 235-45.
36. Soares FA. Increased numbers of pulmonary megakaryocytes in patients with arterial pulmonary tumour embolism and with lung metastases seen at necropsy. J Clin Pathol 1992; 45: 140-2.
37. Masson RG, Ruggieri J. Pulmonary microvascular cytology. A new diagnostic application of the pulmonary artery catheter. Chest 1985; 88: 908-14.
38. Resl M, Kuna P, Petyrek P. Megakaryocytes in rabbit pulmonary blood vessels. Gen Physiol Biophys 1987; 6: 383-6.
39. Warheit DB, Barnhart MI. Circulating megakaryocytes and the microvasculature of the lung. Scan Electron Microsc 1980; 3: 255-62.
40. Martin JF, Slater DN, Trowbridge EA. Abnormal intrapulmonary platelet production: A possible cause of vascular and lung disease. Lancet 1983; i: 793-6.
41. Hachulla E, Rose C, Trillot N, Caulier-Leleu MT, Pasturel-Michon U. What vascular events suggest a myeloproliferative disorder? J Mal Vasc 2000; 25: 382-7.
42. Reisner SA, Rinkevich D, Markiewicz W, Tatarsky I, Brenner B. Cardiac involvement in patients with myeloproliferative disorders. Am J Med 1992; 93: 498-504.
43. Frey BM, Rafii S, Crystal RG, Moore MA. Adenovirus long-term expression of thrombopoietin in vivo: A new model for myeloproliferative syndrome and osteomyelofibrosis. Schweiz Med Wochenschr 1998; 128: 1587-92.
44. Karakus S, Ozcebe OI, Haznedaroglu IC, Göker H, Özatli D, Koalsar A, et al. Circulating thrombopoietin in clonal versus reactive thrombocytosis. Hematology 2002; 7: 9-12.
45. Yamauchi K, Shimamura K. Pulmonary fibrosis with megakaryocytoid cell infiltration and chronic myelogenous leukemia. Leuk Lymphoma 1994; 15: 253-9.
46. Yamauchi K, Oda K, Shimamura K, Arimori S, Nagao T Pulmonary fibrosis with megakaryocytoid cell infiltration in accelerated phase of chronic myelogenous leukaemia. Br J Haematol 1993; 84: 329-31.
47. Wyatt SH. Fishman EK. Diffuse pulmonary extramedullary hematopoiesis in a patient with myelofibrosis: CT findings. J Comput Assist Tomogr 1994; 18: 815-7.